APA (7th ed.) Citation

Hiligsmann, M., Silverman, S., Singer, A., Pearman, L., Wang, Y., Caminis, J., & Reginster, J. (2023). EE137 Comparison of the Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed By Alendronate between US Women and Men at Increased Risk of Fracture. Value in Health, 26(6), S84. https://doi.org/10.1016/j.jval.2023.03.440

Chicago Style (17th ed.) Citation

Hiligsmann, M., S. Silverman, A.J Singer, L. Pearman, Y. Wang, J. Caminis, and J.Y Reginster. "EE137 Comparison of the Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed By Alendronate Between US Women and Men at Increased Risk of Fracture." Value in Health 26, no. 6 (2023): S84. https://doi.org/10.1016/j.jval.2023.03.440.

MLA (9th ed.) Citation

Hiligsmann, M., et al. "EE137 Comparison of the Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed By Alendronate Between US Women and Men at Increased Risk of Fracture." Value in Health, vol. 26, no. 6, 2023, p. S84, https://doi.org/10.1016/j.jval.2023.03.440.